TrialSpinal cord2016

Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial.

M G Fehlings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.